Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 17, 2004

View Archived Issues

LifeSciChannel.com interviews Kalypsys at BIO-Europe 2004

Jak-Stat inhibitor shows promise for the treatment of AML

Toll-like receptor agonist may be an effective immunotherapeutic approach to CLL

Antibody therapy may enhance rituximab-mediated killing in non-Hodgkin's lymphoma

Bionomics receives START grant extension for breast cancer efforts

TS-041 enters phase I study

New conjugate carrier for effective antitumor boron neutron capture therapy

Medicis gains access to Ansata antimicrobial peptide technology

Axaminer demonstrates capabilities in studies

Vion updates phase II Triapine-gemcitabine study in pancreatic cancer

Procyon files IND for PCK-3145

Trillium and Genentech enter global license agreement

Abbott submits Xinlay NDA for metastatic hormone-refractory prostate

Aphton to acquire Igeneon

Aventis scientists prepare and test new oncolytic agents

Schering-Plough claims gamma-secretase inhibitors

Topical formulation for delivery of TRPVI agonists

Combination of CNS stimulant and opioid antagonist covered in Euroceltique patent

Pfizer researchers describe new renin inhibitors for hypertension

NicOx prepares for phase III program of HCT-3012

Two new series of muscarinic receptor antagonists designed at Ranbaxy

Brain tumor compound ECO-4601 enters pharmacology and toxicology trials

Retisert NDA accepted for review

Lunesta approved for treatment of insomnia

Zylet receives FDA approval

Phase III trial and other results for decitabine presented at ASH meeting

BMS-354825 demonstrates activity in resistant chronic myeloid leukemia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...